Skip to main content
OpenTrials
Completed

NCT Number: NCT06600984

WBV on Fascicle Lenght and Knee Joint Angle in CP

This study investigates the effects of WBV on fascicle length, knee joint angle and function in children with spastic hemiplegic cerebral palsy

Completed

Looking for future studies?

Notify Me

Key information

Age range

4 year–6 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

mostafa ALI

Giza, Married, 12668, Egypt

About this study

to study the effect of WBV on fascicle length, knee joint angle and function in children with spastic hemiplegic cerebral palsy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Ages varied from four to six years of both sex
  • hemiplegic CP children, were suffering from knee joint flexion deformity due to hamstring muscles tightness
  • Level I and II motor function, according to the Growth Motor Function Classification System (GMFC) expanded and revised
  • Degree of spasticity ranged from 1 to 2 according to modified Ashworth scale
  • All children received neuro-developmental techniques

Exclusion criteria

  • Other causes of knee flexion deformities
  • Previous history of orthopedic surgery in knee joint
  • Visual or auditory problems
  • Seizures
  • Sensory or perceptual deficits
  • Any acute illness at the time of collection of data.

Treatment and study plan

Whole Body Vibration

Device

On a vibration platform, the children went into a complete squat. The device was calibrated at a frequency of 30 Hz, an amplitude of 2 mm, and a duration of 5 minutes. After the vibration was turned on, the children were told to stay in the squatting position and to report any discomfort that could occur. The vibration automatically shut off after five minutes. The children then rested for a minute. Next, under the identical conditions as for the squatting position, they were instructed to stand on the vibration platform for five minutes with the therapist's assistance. Consequently, WBV was applied for a total of 10 minutes during each session.

Other names: WBV

designed physiotherapy program

Other

structured therapeutic exercise program that included neurodevelopmental approaches, balance exercises, milestone facilitation, stretching exercises, and postural reaction facilitation. The program was conducted for one hour each day, three days a week.

Other names: physical therapy program

Primary outcomes

  1. Knee range of motion

    Time frame: 12 weeks

    Each child in both groups had their knee joint's extension angle measured before and after a 12-week therapy program began using an absolute + AxisTM Digital Goniometer

  2. Fascicle length of hamstring muscle

    Time frame: 12 weeks

    The biceps femoris muscle's muscle fascicle length was measured at a frequency of 7.5 MHz using GE LOGIQ P6 ultrasonography equipment

  3. gross motor function

    Time frame: 12 weeks

    Gross Motor Functional Measurement-88 : is a common principle-test designed to assess changes in function in various milestones for children with cerebral palsy 0 = does not initiate

    • = initiates
    • = partially completes
    • = completes

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Efficacy of Whole Body Vibration on Fascicle Length and Joint Angle in Children With Hemiplegic Cerebral Palsy

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Sep 19, 2024
Registry last updated
Sep 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.